Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
From Modesty to Administration: Self-improvement in Interactive abilities - 2Astronomers spot white dwarf star creating a colorful shockwave
- 3Pick Your #1 game to observe
- 4Yemen’s Aden airport shut by STC-backed transport minister, Saudi source says
- 5Find the Future of Outsourcing: Exploring the Gig Economy
- Exploiting Unsold Rams: May Be Less expensive Than You Suspect
- When will the Epstein files be released — and will they reveal anything new?
- Why screening for the deadliest cancer in the U.S. misses most cases
- How did birds survive while dinosaurs went extinct?
- Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination
- Netanyahu vows to ‘return Negev to Israel,’ pledges settlement growth during visit
- Exploring the Difficulties of Co-Nurturing: Individual Bits of knowledge
- Antivirus Programming for Exhaustive Security
- High Court freezes government move to shutter Army Radio pending ruling
